SCHEMBL5750370

SCHEMBL5750370

NC(=O)c1ccccc1N1C(=O)c2cccc3cccc(c23)C1=O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.59
▸ KMT2A Q03164 7/20 0.59
▸ ALDH1A1 P00352 8/20 0.50
▸ KDM4E B2RXH2 6/20 0.50
▸ POLB P06746 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ THRB P10828 1/20 0.50
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ HPGD P15428 4/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ ERCC1 P07992 1/20 0.49
▸ FEN1 P39748 1/20 0.49
▸ ERCC4 Q92889 1/20 0.49
▸ PDE6D O43924 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30423190 0.87 APEX1 (0.53) ALDH1A1KDM4EPOLBMAPTCA12
SCHEMBL11817098 0.87 APEX1 (0.53) ALDH1A1KDM4EPOLBMAPTCA12
SCHEMBL22717018 0.86 MEN1 (0.60) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL4966777 0.76 POLB (0.83) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL22717016 0.75 ALDH1A1 (0.48) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL20735192 0.74 POLB (0.68) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL13278980 0.73 APEX1 (0.52) ALDH1A1KDM4EPOLBGAAMAPT
N-Phthaloylanthranilic Acid SCHEMBL481284 0.72 APEX1 (0.71) ALDH1A1KDM4EPOLBGAAMAPT
N-Phthaloylanthranilic Acid SCHEMBL29549628 0.72 APEX1 (0.71) ALDH1A1KDM4EPOLBGAAMAPT
SCHEMBL10938557 0.72 ALDH1A1 (0.64) ALDH1A1KDM4EMAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020446-B1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2006-03-15 — — EP claimed
US-6300331-B1 DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 — — US claimed
EP-1020446-A1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP claimed
EP-1020446-B1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2006-03-15 — — EP disclosed
EP-1020446-B1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2006-03-15 — — EP disclosed
EP-1020446-A4 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2001-11-07 — — EP disclosed
US-6300331-B1 DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 — — US disclosed
US-6300331-B1 DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 — — US disclosed
US-6300331-B1 DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 — — US disclosed
EP-1020446-A1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
EP-1020446-A1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
WO-2000001672-A1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-01-13 — — WO disclosed
Send feedback